Table 3.
Final BCVA (logMAR) | PDT Group I N=100 |
IVB Group II N=104 |
TTT Group N=222 |
All N=426 |
---|---|---|---|---|
Minimum | 0.22 | 0.22 | 0.10 | 0.10 |
Maximum | 2.00 | 2.00 | 2.00 | 2.00 |
Median | 0.70 | 1.00 | 1.40 | 1.10 |
Mean | 0.74 | 0.79 | 1.15 | 0.92 |
Std. Dev. Confidence interval | 0.34 (0.67–0.81) | 0.52 (0.69–0.89) | 0.41 (1.10–1.20) | 0.47 (0.88–0.96) |
Distribution analysis- test Shapiro-Wilk | W=0.88 p<0.0001 | W=0.82 p<0.0001 | W=0.59 p<0.0001 | W=0.76 p<0.0001 |
Comparison between groups | Kruskal-Wallis Test H=95.19 p<0.0001; Mann-Whitney Test1,2 Z=−2.79 p=0.0047 Mann-Whitney Test1,3 Z=−9.67 p<0.0001; Mann-Whitney Test2,3 Z=5.05 p<0.0001 |
Mann-Whitney Test1,2 comparison between PDT and IVB; Mann-Whitney Test1,3 comparison between PDT and TTT; Mann-Whitney Test2,3 comparison between IVB and TTT.